Beam Therapeutics, Inc. (BEAM)
25.38
-0.32
(-1.25%)
USD |
NASDAQ |
Oct 12, 13:01
Beam Therapeutics Net Income (TTM) : -85.43M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -85.43M |
| March 31, 2026 | -64.89M |
| December 31, 2025 | -78.90M |
| September 30, 2025 | -413.55M |
| June 30, 2025 | -397.49M |
| March 31, 2025 | -386.40M |
| December 31, 2024 | -376.74M |
| September 30, 2024 | -143.59M |
| June 30, 2024 | -143.01M |
| March 31, 2024 | -134.74M |
| December 31, 2023 | -132.53M |
| September 30, 2023 | -313.67M |
| June 30, 2023 | -327.16M |
| March 31, 2023 | -316.33M |
| December 31, 2022 | -289.09M |
| Date | Value |
|---|---|
| September 30, 2022 | -315.45M |
| June 30, 2022 | -233.99M |
| March 31, 2022 | -238.29M |
| December 31, 2021 | -370.64M |
| September 30, 2021 | -401.40M |
| June 30, 2021 | -407.73M |
| March 31, 2021 | -365.69M |
| December 31, 2020 | -194.59M |
| September 30, 2020 | -126.98M |
| June 30, 2020 | -111.53M |
| March 31, 2020 | -95.17M |
| December 31, 2019 | -78.33M |
| September 30, 2019 | -75.67M |
| June 30, 2019 | -127.82M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Prime Medicine, Inc. | -187.89M |
| Intellia Therapeutics, Inc. | -399.98M |
| Twist Bioscience Corp. | -136.72M |
| Q32 Bio, Inc. | 33.79M |
| Sarepta Therapeutics, Inc. | -266.10M |